Gene · 8295
Papers1,639
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,639
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| mRNA vaccine development for cholangiocarcinoma: a precise pipeline. | Mil Med Res | 2022 | 35821067 | PubTator, text mining | PubMed |
| Structural analysis of the basal state of the Artemis:DNA-PKcs complex. | Nucleic Acids Res | 2022 | 35801871 | PubTator, text mining | PubMed |
| A Designer Nanoparticle Platform for Controlled Intracellular Delivery of Bioactive Macromolecules: Inhibition of Ubiquitin-Specific Protease 7 in Breast Cancer Cells. | ACS Chem Biol | 2022 | 35796308 | PubTator, text mining | PubMed |
| Long noncoding RNA Smyca coactivates TGF-β/Smad and Myc pathways to drive tumor progression. | J Hematol Oncol | 2022 | 35794621 | PubTator, text mining | PubMed |
| TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | EMBO Rep | 2022 | 35785414 | PubTator, text mining | PubMed |
| IGDQ motogenic peptide gradient induces directional cell migration through integrin (αv)β3 activation in MDA-MB-231 metastatic breast cancer cells. | Neoplasia | 2022 | 35763908 | PubTator, text mining | PubMed |
| Insights Into the Biogenesis and Emerging Functions of Lipid Droplets From Unbiased Molecular Profiling Approaches. | Front Cell Dev Biol | 2022 | 35756995 | PubTator, text mining | PubMed |
| TET3 Mediates 5hmC Level and Promotes Tumorigenesis by Activating AMPK Pathway in Papillary Thyroid Cancer. | Int J Endocrinol | 2022 | 35755313 | PubTator, text mining | PubMed |
| A dual-activity topoisomerase complex regulates mRNA translation and turnover. | Nucleic Acids Res | 2022 | 35748872 | PubTator, text mining | PubMed |
| Two Genetic Mechanisms in Two Siblings with Intellectual Disability, Autism Spectrum Disorder, and Psychosis. | J Pers Med | 2022 | 35743796 | PubTator, text mining | PubMed |
| MTBP and MYC: A Dynamic Duo in Proliferation, Cancer, and Aging. | Biology (Basel) | 2022 | 35741402 | PubTator, text mining | PubMed |
| Deep Sequencing of Early T Stage Colorectal Cancers Reveals Disruption of Homologous Recombination Repair in Microsatellite Stable Tumours with High Mutational Burdens. | Cancers (Basel) | 2022 | 35740599 | PubTator, text mining | PubMed |
| Robust prognostic model based on immune infiltration-related genes and clinical information in ovarian cancer. | J Cell Mol Med | 2022 | 35735060 | PubTator, text mining | PubMed |
| Longitudinal Study of DNA Methylation and Epigenetic Clocks Prior to and Following Test-Confirmed COVID-19 and mRNA Vaccination. | Front Genet | 2022 | 35719387 | PubTator, text mining | PubMed |
| Mechanisms that regulate the activities of TET proteins. | Cell Mol Life Sci | 2022 | 35705880 | PubTator, text mining | PubMed |
| Oncogenic ZMYND11-MBTD1 fusion protein anchors the NuA4/TIP60 histone acetyltransferase complex to the coding region of active genes. | Cell Rep | 2022 | 35705031 | PubTator, text mining | PubMed |
| Transcriptome sequencing reveals altered ciliogenesis under hypoxia in nasal epithelial cells from chronic rhinosinusitis with nasal polyps. | Clin Transl Allergy | 2022 | 35702726 | PubTator, text mining | PubMed |
| Regulation of RASSF by non-coding RNAs in different cancers: RASSFs as masterminds of their own destiny as tumor suppressors and oncogenes. | Noncoding RNA Res | 2022 | 35702574 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. | Toxicol Appl Pharmacol | 2022 | 35688186 | PubTator, text mining | PubMed |
| Stress- and metabolic responses of Candida albicans require Tor1 kinase N-terminal HEAT repeats. | PLoS Pathog | 2022 | 35687592 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8295/papers?page=13